Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2010-11-18
pubmed:abstractText
BBR3610 is a polynuclear platinum compound, in which two platinums are linked by a spermine-like linker, and studies in a variety of cancers, including glioma, have shown that it is more potent than conventional platinums and works by different means. Identifying the mechanism of action of BBR3610 would help in developing the drug further for clinical use. Previous work showed that BBR3610 does not induce immediate apoptosis but results in an early G2/M arrest. Here, we report that BBR3610 induces early autophagy in glioma cells. Increased autophagy was also seen in intracranial xenografts treated with BBR3610. Interestingly, upon attenuation of autophagy by RNAi-mediated knockdown of ATG5 or ATG6/BECN1, no change in cell viability was observed, suggesting that the autophagy is neither an effective protection against BBR3610 nor an important part of the mechanism by which BBR3610 reduces glioma cell viability. This prompted a multimodal analysis of 4 cell lines over 2 weeks posttreatment with BBR3610, which showed that the G2/M arrest occurred early and apoptosis occurred later in all cell lines. The cells that survived entered a senescent state associated with mitotic catastrophe in 2 of the cell lines. Together, our data show that the response to treatment with a single agent is complex and changes over time.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1523-5866
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1269-77
pubmed:dateRevised
2011-5-27
pubmed:meshHeading
pubmed-meshheading:20713409-Animals, pubmed-meshheading:20713409-Antineoplastic Agents, pubmed-meshheading:20713409-Apoptosis, pubmed-meshheading:20713409-Apoptosis Regulatory Proteins, pubmed-meshheading:20713409-Autophagy, pubmed-meshheading:20713409-Blotting, Western, pubmed-meshheading:20713409-Brain Neoplasms, pubmed-meshheading:20713409-Cell Division, pubmed-meshheading:20713409-Cell Line, Tumor, pubmed-meshheading:20713409-Cisplatin, pubmed-meshheading:20713409-Drug Therapy, Combination, pubmed-meshheading:20713409-G2 Phase, pubmed-meshheading:20713409-Glioma, pubmed-meshheading:20713409-Humans, pubmed-meshheading:20713409-Membrane Proteins, pubmed-meshheading:20713409-Mice, pubmed-meshheading:20713409-Mice, Nude, pubmed-meshheading:20713409-Microtubule-Associated Proteins, pubmed-meshheading:20713409-Organoplatinum Compounds, pubmed-meshheading:20713409-RNA, Small Interfering, pubmed-meshheading:20713409-Signal Transduction, pubmed-meshheading:20713409-Tumor Cells, Cultured, pubmed-meshheading:20713409-Xenograft Model Antitumor Assays
pubmed:year
2010
pubmed:articleTitle
The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.
pubmed:affiliation
Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural